The key opinion leader management market is estimated at USD 87.4 billion in 2026 and is forecast to register a 9.8% CAGR between 2026 and 2036. In 2026, oncology holds 35% of medical speciality sales and pharmaceutical and biotechnology companies represent 47.6% within the end user segment.